Observational studyBMC medical imaging2026
A prospective comparison of ultrawide-field and two-field fundus imaging for diabetic retinopathy assessment.
Observational study in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05836194 (Comparison of Ultra-Widefield Scanning Laser Ophthalmoscopy and Two-Field Fundus Photography for Evaluating Diabetic Retinopathy), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Comparison of Ultra-Widefield Scanning Laser Ophthalmoscopy and Two-Field Fundus Photography for Evaluating Diabetic Retinopathy
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundTo evaluate the efficacy of nonmydriatic ultrawide-field (UWF) imaging in diagnosing diabetic retinopathy (DR) compared to nonmydriatic 2-field 45° fundus photography (FP).
methodsA total of 769 eyes with diabetes were included in this prospective, observational, comparative, real-world study. We captured both nonmydriatic 2-field 45° FP and UWF images for each patient. Both imaging modalities were analyzed according to the International Classification of Diabetic Retinopathy Disease Severity Scale to assess agreement in DR grading and image gradability. We also investigated DR lesions visible in UWF images beyond and within the scope of the 2-field 45° fundus images.
resultsUWF imaging and 2-field 45° FP showed substantial agreement in DR grading (weighted κ = 0.798), which decreased to moderate agreement (weighted κ = 0.495) after excluding the eyes graded as ‘no DR’ in both modalities. UWF imaging yielded higher severity grades in 14.33% of cases (87 eyes). A statistically significant difference was observed between UWF imaging and 2-field 45° FP in detecting DR (56.96% vs. 44.47%, p < 0.0001) and referable DR (46.81% vs. 36.02%, p < 0.0001). Among the 369 DR-affected eyes, 24.39% exhibited lesions mainly within the central field, 45.25% showed primarily peripheral lesions, and 30.35% presented lesions uniformly distributed. UWF imaging demonstrated a significantly lower ungradable rate for DR assessment compared to 2-field 45° FP (3.77% vs. 19.90%, p < 0.0001).
conclusionsUWF imaging offers significant advantages over 2-field 45° FP in DR detection, severity grading, and image gradability, demonstrating strong potential to enhance clinical DR management.
trial registrationThis study was registered with ClinicalTrials.gov (NCT05836194) on May 1, 2023.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.